Navigation Links
Transition Therapeutics to Present at 2008 Morgan Stanley Global Healthcare Unplugged Conference
Date:4/28/2008

TORONTO, April 28 /PRNewswire-FirstCall/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ:TTHI, TSX:TTH) today announced that Dr. Tony Cruz, Chairman and Chief Executive Officer, will present at the upcoming Morgan Stanley Global Healthcare Unplugged Conference. Dr. Cruz's presentation will take place on Friday, May 2, 2008 at 10:30 A.M. (Eastern Time) at the Ritz-Carlton in Key Biscayne, Florida.

About Transition

----------------

Transition is a biopharmaceutical company, developing novel therapeutics for disease indications with large markets. Transition's lead products include ELND005 (AZD-103) for the treatment of Alzheimer's disease and TT-223 for the treatment of diabetes. Transition has an emerging pipeline of preclinical drug candidates acquired externally and developed internally using its proprietary drug discovery engine. Transition's shares are listed on the NASDAQ under the symbol "TTHI" and the Toronto Stock Exchange under the symbol "TTH". For additional information about the Company, please visit http://www.transitiontherapeutics.com.

Notice to Readers: Information contained in our press releases should be considered accurate only as of the date of the release and may be superseded by more recent information we have disclosed in later press releases, filings with the OSC, SEC or otherwise. Except for historical information, this press release may contain forward-looking statements, relating to expectations, plans or prospects for Transition, including conducting clinical trials. These statements are based upon the current expectations and beliefs of Transition's management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include factors beyond Transition's control and the risk factors and other cautionary statements discussed in Transition's quarterly and annual filings with the Canadian commissions.


'/>"/>
SOURCE Transition Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Transitioning patients with pediatric disease to adulthood
2. American Lung Association Offers Smoke-Free Transition Help to Businesses
3. Institute for Integrative Nutrition Provides Tips to Transition Bodies for Fall, Winter, Spring, Summer Eating
4. Transition Therapeutics to Present at Cowen & Company 28th Annual Healthcare Conference
5. APhA Announces Plans for Executive Leadership Transition
6. Jan Marini Skin Research Introduces Age Intervention(R) Transitions - a New Frontier in Skin Care
7. AUDIO from Medialink and Transitions: Understanding the Dangers of UV Rays
8. Cliff Consulting, Inc. Transitions to Woman-Owned and Managed Firm With Robin Nasatirs Promotion to President/Chief Operating Officer
9. Transitionz Wellness Boutique Launches with Grand Opening Discounts
10. Transition Therapeutics Announces Second Quarter Fiscal 2008 Financial Results
11. Transitions Optical Promotes Healthy Sight Through a Nationwide Integrated Advertising Campaign and the Launch of an Enhanced Consumer Web Site
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... ... February 20, 2017 , ... Today, ... health plan partners, announced during the 2017 Annual HIMSS Conference & Exhibition ... for diabetic patients and integrating eye care into mainstream healthcare delivery is ...
(Date:2/19/2017)... ... February 19, 2017 , ... Braun Industries will be participating as ... the event will take place February 23-25, 2017 at the Calvin L. Rampton Salt ... #909 with three new ambulances on display. , “JEMS is a ...
(Date:2/19/2017)... , ... February 19, 2017 , ... ... for connected home healthcare, will join forces with Healthwise ® at ... Healthwise, the industry leader in evidence-based health education, technology and services, will ...
(Date:2/18/2017)... ... February 17, 2017 , ... Butler Mobility invited Ken Matthews to ... other Butler products. Ken was impressed with the safety and reliability of the ... product on his show. This endorsement by Ken Matthews can be heard on ...
(Date:2/18/2017)... ... February 18, 2017 , ... ... Use Pixel Film Studios ’ ProParagraph Fashion Volume 2 for all multi-line ... other applications. Users can pick and choose from hand-crafted trend-setting designs with ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... 20, 2017 According to a new market research ... powder), Device Type (Metered dose, Dry Powder, Nebulizer)), Canister (Plain, Coated), End ... The market is projected to reach USD 52.37 Billion by 2021 from ... forecast period. Continue Reading ... ...
(Date:2/20/2017)... -- Acute, Chronic and Prophylaxis GVHD The global ... of 7% from 2016-2021 and CAGR of 3% from 2021-2027. The market ... 2027. The market is estimated at $0.36bn in 2016, $0.51bn in 2021, ... How ... can exploit the future business opportunities emerging in this sector. ...
(Date:2/19/2017)... and ORLANDO, Fla. , ... NKTR ) today announced that positive Phase 1 ... patients with renal cell carcinoma (RCC) were presented at ... designed to expand specific cancer-fighting T cells and Natural ... and increase expression of PD-1 on these immune cells.  ...
Breaking Medicine Technology: